INTRODUCTIONHuman immunodeficiency virus (HIV) is an incurable viral infection that weakens the immune system by entering, replicating within, and destroying CD4+ T cells. Recently, the Centers for Disease Control and…
Read More
INTRODUCTIONSkin aging is characterized by exhaustion of stem cell pools, and declining migration and differentiation of cutaneous stem cells. Associated DNA damage, epigenetic alterations, and mitochondrial dysfunction are regulated by…
Read More
BACKGROUNDThe lower cutaneous lip represents an important aesthetic subunit of the face, and regional reconstruction aims to preserve the function and appearance of the adjacent oral aperture and chin. This…
Read More
INTRODUCTIONThe electromagnetic spectrum is the range of all possible frequencies of electromagnetic radiation and is arranged based on wavelength, from shortest to longest (gamma rays, X-rays, ultraviolet (UV) rays, visible…
Read More
INTRODUCTIONCutaneous T-Cell Lymphoma (CTCL) is a heterogeneous group of Non-Hodgkin’s lymphomas arising from mature T-cells. CTCL is a rare but important entity for all dermatologists to become familiar with in…
Read More
INTRODUCTIONThe seborrheic keratosis (SK), which is ubiquitous throughout all populations, is a benign tumor of the skin. Nomenclature for the SK includes seborrheic wart, seborrheic verruca, basal cell papilloma, pigmented…
Read More
BACKGROUNDFollowing a diagnosis of cutaneous malignant melanoma (CMM), patients are often guided for subsequent management by their dermatologist and national guideline recommendations.1,2 Based upon staging classification for CMM, guidelines recommend…
Read More
INTRODUCTIONIngenol mebutate gel 0.015% provides high clearance rates for actinic keratosis (AK) on the face and scalp1 but causes transient local skin responses (LSRs): erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, and…
Read More
INTRODUCTIONIndications, strengths, and dosages of ingenol mebutate (IngMeb) gel apply to its use on one contiguous skin area of approximately 25 cm2 for the topical treatment of actinic keratosis (AK).1,2…
Read More
INTRODUCTIONNonmelanoma skin cancer (NMSC) is the most common malignancy in the US1 Primary prevention of NMSC with physical photoprotective measures are often not sufficient to impact skin cancer incidence in…
Read More
INTRODUCTIONThere are an estimated 3.5 million cases of non-melanoma skin cancer (NMSC), and over 100,000 new cases of malignant melanoma (MM) in the United States each year.1-6 The incidence of…
Read More
INTRODUCTIONThe incidence of non-melanoma skin cancer (NMSC) in the United States is approximately 5 million annual cases per year.1 While surgery is the gold standard for the management of NMSC,…
Read More
